Build status - In Progress

Trial to Study an Investigational Drug Pravastatin to Prevent Preeclampsia in High-Risk Pregnant Women

Recruiting
16 years - 99 years
All
6 participants needed
1 Location

Brief description of study

Preeclampsia is a serious medical condition that can happen during pregnancy. It usually starts with increasing blood pressure and could affect liver, kidney or other organ functions. This study will to assess whether daily treatment with investigational drug pravastatin administered early in pregnancy reduces the rate of preeclampsia in high-risk women. Participation will last approximately 5 years and 7 months and will include approximately 12 study visits to the study center. Participants compensated maximum $450.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pregnant, Pregnancy, Preeclampsia
  • Age: 16 years - 99 years
  • Gender: All

16 Years or Older Pregnant Women High Risk for Preeclampsia

Updated on 04 Aug 2024. Study ID: 833740

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center